Natural antioxidant dihydroxybenzyl alcohol blocks ritonavir-induced endothelial dysfunction in porcine pulmonary arteries and human endothelial cells
Author(s) -
Sarah M. Weakley,
Jun Jiang,
Jinhu Lü,
Xinwen Wang,
Peter H. Lin,
Qizhi Yao,
Changyi Chen
Publication year - 2011
Publication title -
medical science monitor
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.636
H-Index - 85
eISSN - 1643-3750
pISSN - 1234-1010
DOI - 10.12659/msm.881926
Subject(s) - oxidative stress , antioxidant , pharmacology , ritonavir , reactive oxygen species , medicine , glutathione , enos , endothelial dysfunction , nitric oxide , endothelium , chemistry , biochemistry , nitric oxide synthase , immunology , enzyme , viral load , human immunodeficiency virus (hiv) , antiretroviral therapy
Patients with HIV have an increased incidence of pulmonary artery hypertension. This study was designed to determine if the naturally occurring antioxidant dihydroxybenzyl alcohol (DHBA) could counteract the deleterious effects of ritonavir (RTV), an HIV-protease inhibitor known to impair endothelial function and increase oxidative stress.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom